FindTrial
Sign In

A study to compare the clinical efficacy & safety of equal doses of Hyperbaric ropivacaine vs Hyperbaric bupivacaine for sub arachnoid block in knee arthroscopic surgery.

A comparative evaluation of 0.75% hyperbaric ropivacaine vs 0.5% hyperbaric bupivacaine for subarachnoid block in knee arthroscopic surgery. A randomised prospective double blind study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057327
Enrollment
80
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S832- Tear of meniscus, current injury Health Condition 2: S832- Tear of meniscus, current injury

Interventions

Intervention1: HYPERBARIC ROPIVACAINE: To evaluate the clinical efficacy and safety 3ml of 0.75 % Hyperbaric ropivacaine for sub arachnoid block in knee arthroscopic surgery for a duration of 16 to18

Sponsors

FORTIS HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willing to participate, ASA grade 1 and 2, Age- 16-65 years, Either gender scheduled for elective knee arthroscopic surgery under spinal anaesthesia, Pt with BMI less then 35, Patients who have given valid informed written consent.

Exclusion criteria

Exclusion criteria: Patients of American society of Anaesthesiologists 3 and 4, Patient refusal , Infection at the site of administration, Coagulopathy , Spinal deformity, Allergic to local anesthetic drugs , Lack of informed written consent , Duration of surgery greater than 120 mins, Patients having allergy to study drug, Patients with psychiatric disorder or history of drug abuse. Patient unable to comprehend, Morbidly obese patients (BMI greater than 35kg per m2), Pregnant patients.

Design outcomes

Primary

MeasureTime frame
To compare the clinical efficacy & safety of equal doses 3ml of 0.75 % Hyperbaric ropivacaine with 3ml of 0.5% Hyperbaric bupivacaine for sub arachnoid block in knee arthroscopic surgery for a duration of 16 to 18 months Timepoint: 1.The onset of Sensory block till T 10 2.The onset of Motor block. 3.Time for two segment regression of sensory block 4.The complete duration of sensory & motor block 5.Intraoperative Haemodynamics. 6.Intraoperative complications. 7.Time to first rescue analgesic. 8.Time to micturition. for a duration of 16 to 18 months—

Secondary

MeasureTime frame
To study & compare the side effect profile of the two drugs, To study the intraoperative and post operative complications. Timepoint: Intraoperative vitals at 1min, 5min,10min,15min,20min,25min,30min,45min,60min,75min,90min,120min Post operative vitals at 0min,30min,1hr,1.5hr,2hr,2.5hr,3hr.—

Countries

India

Contacts

Public ContactDr Dinesh Kataria

Fortis Hosptial Mohali

drkat22in@gmail.com9872217274

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026